Cargando…
Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study
OBJECTIVES: The study aimed to explore patients’ experiences of experimental cancer medicine (ECM) clinical trials. DESIGN: The study’s design was qualitative. Two focus groups with patients were undertaken followed by semistructured interviews, to explore patients’ experiences of ECM clinical trial...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493921/ https://www.ncbi.nlm.nih.gov/pubmed/34610932 http://dx.doi.org/10.1136/bmjopen-2020-047813 |
_version_ | 1784579212404850688 |
---|---|
author | Sawyer, Chelsea Preston, Laurie Taylor, Sally Davies, Michelle Carter, Louise Krebs, Matthew Cook, Natalie Graham, Donna Thistlethwaite, Fiona Yorke, Janelle |
author_facet | Sawyer, Chelsea Preston, Laurie Taylor, Sally Davies, Michelle Carter, Louise Krebs, Matthew Cook, Natalie Graham, Donna Thistlethwaite, Fiona Yorke, Janelle |
author_sort | Sawyer, Chelsea |
collection | PubMed |
description | OBJECTIVES: The study aimed to explore patients’ experiences of experimental cancer medicine (ECM) clinical trials. DESIGN: The study’s design was qualitative. Two focus groups with patients were undertaken followed by semistructured interviews, to explore patients’ experiences of ECM clinical trials. Interviews and focus groups were audiorecorded and transcribed verbatim. Data were analysed using thematic analysis. SETTING: A regional cancer centre (tertiary care) in North-West England. PARTICIPANTS: Twelve patients (aged 52–79) participated in one of the two focus groups and 22 patients (aged 42–83) participated in interviews. PRIMARY OUTCOME MEASURE: Patients’ experiences of an ECM trial. RESULTS: Four main themes were identified from the analysis: decision making, information needs, the experience of trial participation and impact of trial participation. Subthemes are presented in the manuscript. CONCLUSION: To make fully informed decisions about trial participation, patients required the simplification of trial information and wanted more information about side effects, their response to trial treatment and the overall trial progress throughout the trial. Patients highlighted the need for improvement for the support provided to their family and friends. |
format | Online Article Text |
id | pubmed-8493921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-84939212021-10-14 Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study Sawyer, Chelsea Preston, Laurie Taylor, Sally Davies, Michelle Carter, Louise Krebs, Matthew Cook, Natalie Graham, Donna Thistlethwaite, Fiona Yorke, Janelle BMJ Open Oncology OBJECTIVES: The study aimed to explore patients’ experiences of experimental cancer medicine (ECM) clinical trials. DESIGN: The study’s design was qualitative. Two focus groups with patients were undertaken followed by semistructured interviews, to explore patients’ experiences of ECM clinical trials. Interviews and focus groups were audiorecorded and transcribed verbatim. Data were analysed using thematic analysis. SETTING: A regional cancer centre (tertiary care) in North-West England. PARTICIPANTS: Twelve patients (aged 52–79) participated in one of the two focus groups and 22 patients (aged 42–83) participated in interviews. PRIMARY OUTCOME MEASURE: Patients’ experiences of an ECM trial. RESULTS: Four main themes were identified from the analysis: decision making, information needs, the experience of trial participation and impact of trial participation. Subthemes are presented in the manuscript. CONCLUSION: To make fully informed decisions about trial participation, patients required the simplification of trial information and wanted more information about side effects, their response to trial treatment and the overall trial progress throughout the trial. Patients highlighted the need for improvement for the support provided to their family and friends. BMJ Publishing Group 2021-10-04 /pmc/articles/PMC8493921/ /pubmed/34610932 http://dx.doi.org/10.1136/bmjopen-2020-047813 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Oncology Sawyer, Chelsea Preston, Laurie Taylor, Sally Davies, Michelle Carter, Louise Krebs, Matthew Cook, Natalie Graham, Donna Thistlethwaite, Fiona Yorke, Janelle Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study |
title | Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study |
title_full | Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study |
title_fullStr | Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study |
title_full_unstemmed | Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study |
title_short | Oncology patients’ experiences in experimental medicine cancer trials: a qualitative study |
title_sort | oncology patients’ experiences in experimental medicine cancer trials: a qualitative study |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493921/ https://www.ncbi.nlm.nih.gov/pubmed/34610932 http://dx.doi.org/10.1136/bmjopen-2020-047813 |
work_keys_str_mv | AT sawyerchelsea oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy AT prestonlaurie oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy AT taylorsally oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy AT daviesmichelle oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy AT carterlouise oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy AT krebsmatthew oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy AT cooknatalie oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy AT grahamdonna oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy AT thistlethwaitefiona oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy AT yorkejanelle oncologypatientsexperiencesinexperimentalmedicinecancertrialsaqualitativestudy |